Reviva Pharmaceuticals
RVPH----
Forecast & Rating2 analysts currently cover Reviva Pharmaceuticals, of which 1 give a positive rating. The average price target is $17.50, about 3331.4% upside from the current price of $0.51. Coverage is limited, so the data is for reference only. Data as of Aug 21, 2026; this does not constitute investment advice.
Aug 17, 2026Price forecast
$17.503331.37%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateOct 5, 2026
Forecast met0.0%
Stock price$0.51
Avg. target$17.5
High target$30
Low target$5
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.